Skip to main content

Table 1 Patient characteristics

From: A phase I/II study of weekly nab-paclitaxel plus cisplatin in chemotherapy-naïve patients with advanced non-small-cell lung cancer

Characteristics n = 22
AgeMedian (range)67.5 (37–75)
Sex, n (%)Male20 (90.9)
Female2 (9.1)
ECOG PS, n (%)04 (18.2)
118 (81.8)
Smoking history, n (%)Never0 (0.0)
Ever/current22 (100)
Histology, n (%)Adenocarcinoma10 (45.5)
Squamous cell carcinoma7 (31.8)
NSCLC, NOS5 (22.7)
Stage (UICC7), n (%)IIIB4 (18.2)
IV18 (81.8)
Postoperative recurrence0 (0.0)
EGFR mutation, n (%)Negative21 (95.5)
Unknown1 (4.5)
ALK transfusion, n (%)Negative20 (90.9)
Unknown2 (9.1)